lifestyle.californiaconsumerbanking.com

Author: BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

April 30, 2026
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

March 11, 2026
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

March 10, 2026
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

January 28, 2026
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

January 27, 2026